{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:19:51Z","timestamp":1791638391016,"version":"4.3.4"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA036727"],"award-info":[{"award-number":["CA036727"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0308"],"award-info":[{"award-number":["W81XWH-18-1-0308"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5 R44 CA235991"],"award-info":[{"award-number":["5 R44 CA235991"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA247471"],"award-info":[{"award-number":["R01 CA247471"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA185148"],"award-info":[{"award-number":["U01 CA185148"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bbcan.2022.188737","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:27:50Z","timestamp":1654514870000},"page":"188737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The Pleiotropic role, functions and targeted therapies of LIF\/LIFR axis in cancer: Old spectacles with new insights"],"prefix":"10.1016","volume":"1877","author":[{"given":"Sushanta","family":"Halder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Parte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakthivel","family":"Muniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hareesh B.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathy","family":"Seshacharyulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2022.188737_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2019.02.042","article-title":"Phosphorylation of LIFR promotes prostate cancer progression by activating the AKT pathway","volume":"451","author":"Shao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2022.188737_bb0010","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1158\/1078-0432.CCR-18-3239","article-title":"Leukemia inhibitory factor promotes castration-resistant prostate cancer and neuroendocrine differentiation by activated ZBTB46","volume":"25","author":"Liu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0015","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1242\/dev.117598","article-title":"LIF signaling in stem cells and development","volume":"142","author":"Onishi","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2022.188737_bb0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1515\/REVNEURO.2008.19.4-5.341","article-title":"Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration","volume":"19","author":"Dziennis","year":"2008","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bbcan.2022.188737_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00005-021-00605-w","article-title":"Leukemia inhibitory factor: a potential biomarker and therapeutic target in pancreatic cancer","volume":"69","author":"Wrona","year":"2021","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.bbcan.2022.188737_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yexmp.2013.06.012","article-title":"Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma","volume":"95","author":"Kuphal","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/apm.12427","article-title":"Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3","volume":"123","author":"Liu","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.bbcan.2022.188737_bb0040","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/ncomms6218","article-title":"LIF negatively regulates tumour-suppressor p53 through Stat3\/ID1\/MDM2 in colorectal cancers","volume":"5","author":"Yu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2022.188737_bb0045","first-page":"146","article-title":"Correlations of leukemia inhibitory factor and macrophage migration inhibitory factor with endometrial carcinoma","volume":"36","author":"Xiao","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0050","doi-asserted-by":"crossref","first-page":"788","DOI":"10.18632\/oncotarget.1772","article-title":"LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2022.188737_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107754","article-title":"The emerging role of leukemia inhibitory factor in cancer and therapy","volume":"221","author":"Zhang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2022.188737_bb0060","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/1541-7786.MCR-20-0633","article-title":"Mutant KRAS downregulates the receptor for leukemia inhibitory factor (LIF) to enhance a signature of glycolysis in pancreatic cancer and lung cancer","volume":"19","author":"Liu","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/nyas.14466","article-title":"Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway","volume":"1484","author":"Bian","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbcan.2022.188737_bb0070","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1172\/JCI63428","article-title":"Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance","volume":"123","author":"Liu","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2022.188737_bb0075","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41420-021-00603-z","article-title":"LIF\/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer","volume":"7","author":"Tang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2022.188737_bb0080","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nm.2940","article-title":"LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker","volume":"18","author":"Chen","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2022.188737_bb0085","first-page":"2769","article-title":"LIFR promotes tumor angiogenesis by up-regulating IL-8 levels in colorectal cancer","volume":"2018","author":"Wu","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2022.188737_bb0090","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41388-017-0026-x","article-title":"Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4","volume":"37","author":"Lv","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0095","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41388-018-0456-0","article-title":"A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERalpha-positive breast cancer cells","volume":"38","author":"Li","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0100","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/tox.23104","article-title":"Hsa_circ_0001073 targets miR-626\/LIFR axis to inhibit lung cancer progression","volume":"36","author":"Liu","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","article-title":"Leukemia inhibitory factor (LIF)","volume":"26","author":"Nicola","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbcan.2022.188737_bb0110","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/j.1460-2075.1987.tb02742.x","article-title":"Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF)","volume":"6","author":"Gearing","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2022.188737_bb0115","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1016\/S0021-9258(18)90609-5","article-title":"Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells","volume":"259","author":"Tomida","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2022.188737_bb0120","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/336688a0","article-title":"Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides","volume":"336","author":"Smith","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2022.188737_bb0125","first-page":"270","article-title":"Clonal suppression of HL60 and U937 cells by recombinant human leukemia inhibitory factor in combination with GM-CSF or G-CSF","volume":"3","author":"Maekawa","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2022.188737_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.693724","article-title":"Emerging perspectives on leukemia inhibitory factor and its receptor in cancer","volume":"11","author":"Christianson","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/geno.1993.1441","article-title":"The leukemia inhibitory factor receptor (LIFR) gene is located within a cluster of cytokine receptor loci on mouse chromosome 15 and human chromosome 5p12-p13","volume":"18","author":"Gearing","year":"1993","journal-title":"Genomics"},{"issue":"Pt 3","key":"10.1016\/j.bbcan.2022.188737_bb0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1042\/bj3280879","article-title":"Structure of the mouse leukaemia inhibitory factor receptor gene: regulated expression of mRNA encoding a soluble receptor isoform from an alternative 5' untranslated region","volume":"328","author":"Chambers","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2022.188737_bb0145","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1158\/1535-7163.MCT-19-0605","article-title":"Stem cell factor lifted as a promising clinical target for cancer therapy","volume":"18","author":"Shi","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2022.188737_bb0150","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/emboj\/19.11.2399","article-title":"Receptor recognition by gp130 cytokines","volume":"19","author":"Bravo","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2022.188737_bb0155","doi-asserted-by":"crossref","first-page":"27169","DOI":"10.1074\/jbc.M303168200","article-title":"Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor","volume":"278","author":"Plun-Favreau","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2022.188737_bb0160","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1038\/s41388-019-0703-z","article-title":"TGFbeta promotes breast cancer stem cell self-renewal through an ILEI\/LIFR signaling axis","volume":"38","author":"Woosley","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1086\/381715","article-title":"Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann\/Schwartz-Jampel type 2 syndrome","volume":"74","author":"Dagoneau","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbcan.2022.188737_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212032","article-title":"Stuve-Wiedemann syndrome with a novel mutation","volume":"2015","author":"Knipe","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000407418","article-title":"Intragenic deletion in the LIFR gene in a long-term survivor with stuve-Wiedemann syndrome","volume":"6","author":"Hatagami Marques","year":"2015","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-9-34","article-title":"Stuve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology","volume":"9","author":"Mikelonis","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbcan.2022.188737_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrfmmm.2019.111677","article-title":"Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients","volume":"816-818","author":"Real","year":"2019","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2009.08.013","article-title":"Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array","volume":"289","author":"Okamura","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2022.188737_bb0195","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.hep.2003.09.029","article-title":"DNA methylation controls the responsiveness of hepatoma cells to leukemia inhibitory factor","volume":"38","author":"Blanchard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2022.188737_bb0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2407-5-145","article-title":"Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines","volume":"5","author":"Loewen","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2022.188737_bb0205","first-page":"337","article-title":"Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinoma","volume":"39","author":"Cho","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fgene.2017.00097","article-title":"Simultaneous methylation-level assessment of hundreds of CpG sites by targeted bisulfite PCR sequencing (TBPseq)","volume":"8","author":"Jeon","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2022.188737_bb0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13058-017-0865-y","article-title":"miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer","volume":"19","author":"Wang","year":"2017","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0220","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1101\/gr.219741.116","article-title":"Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers","volume":"27","author":"Wang","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11010-018-3366-0","article-title":"miR-377-3p regulates adipogenic differentiation of human bone marrow mesenchymal stem cells by regulating LIFR","volume":"449","author":"Li","year":"2018","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.bbcan.2022.188737_bb0230","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s10620-021-07055-6","article-title":"Lidocaine suppresses gastric cancer development through Circ_ANO5\/miR-21-5p\/LIFR Axis","volume":"67","author":"Guan","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbcan.2022.188737_bb0235","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s13238-011-1113-3","article-title":"c-Jun, at the crossroad of the signaling network","volume":"2","author":"Meng","year":"2011","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbcan.2022.188737_bb0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13046-018-0821-4","article-title":"miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K\/AKT-c-Jun regulatory feedback loop","volume":"37","author":"Zhang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0245","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820983293","article-title":"A competing endogenous RNA network reveals novel lncRNA, miRNA and mRNA biomarkers with diagnostic and prognostic value for early breast cancer","volume":"19","author":"Luo","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2022.188737_bb0250","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/cas.13592","article-title":"Long non-coding RNA-CTD-2108O9.1 represses breast cancer metastasis by influencing leukemia inhibitory factor receptor","volume":"109","author":"Wang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2022.188737_bb0255","article-title":"miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR","volume":"100567","author":"Tan","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0260","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/hep.28781","article-title":"N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor\/MicroRNA-181c negative feedback pathway","volume":"64","author":"Wang","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2022.188737_bb0265","first-page":"2871","article-title":"Functional role of a long non-coding RNA LIFR-AS1\/miR-29a\/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy","volume":"2018","author":"Liu","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2022.188737_bb0270","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180551","article-title":"LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0275","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12935-020-01228-5","article-title":"lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p\/ZNF471 axis","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2022.188737_bb0280","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1080\/15384101.2021.1991122","article-title":"M(6)A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p\/VEGFA\/Akt signaling","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2022.188737_bb0285","first-page":"5378","article-title":"High long non-coding LIFR-AS1 expression correlates with poor survival in gastric carcinoma","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2022.188737_bb0290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12935-020-01644-7","article-title":"LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p\/COL1A2 axis","volume":"21","author":"Pan","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2022.188737_bb0295","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00432-015-2071-6","article-title":"A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion","volume":"142","author":"Zhao","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0300","article-title":"lncRNA LIFRAS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR4698","volume":"23","author":"Zhao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0305","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/01616412.2020.1836465","article-title":"Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262\/NF-kappaB pathway in glioma","volume":"43","author":"Ding","year":"2021","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0310","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1080\/15384101.2021.1995129","article-title":"Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p\/SIDT2 axis","volume":"20","author":"Yi","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2022.188737_bb0315","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13205-021-02739-2","article-title":"Long non-coding RNA LIFR-AS1 regulates the proliferation, migration and invasion of human thyroid cancer cells","volume":"11","author":"Li","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.bbcan.2022.188737_bb0320","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ymthe.2020.06.013","article-title":"Novel long non-coding RNA lncAMPC promotes metastasis and immunosuppression in prostate cancer by stimulating LIF\/LIFR expression","volume":"28","author":"Zhang","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2022.188737_bb0325","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1111\/cas.14131","article-title":"Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)-182\/miR-93-leukemia inhibitory factor receptor pathway","volume":"110","author":"Wang","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2022.188737_bb0330","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/OTT.S283026","article-title":"Circular RNA circARPP21 acts as a sponge of miR-543 to suppress hepatocellular carcinoma by regulating LIFR","volume":"14","author":"Gu","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188737_bb0335","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10735-021-10044-8","article-title":"Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p\/miR-222-3p to block gastric cancer development","volume":"53","author":"Zheng","year":"2022","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0340","first-page":"699","article-title":"Role of leukemia inhibitory factor during mammalian development","volume":"7","author":"Shellard","year":"1996","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bbcan.2022.188737_bb0345","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1634\/stemcells.22-5-770","article-title":"LIF\/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells","volume":"22","author":"Daheron","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2022.188737_bb0350","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/dbio.1998.9026","article-title":"Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway","volume":"203","author":"Dani","year":"1998","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/450619a","article-title":"Reproduction: the unusual suspect","volume":"450","author":"Stewart","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2022.188737_bb0360","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1073\/pnas.151180898","article-title":"Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation","volume":"98","author":"Cheng","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2022.188737_bb0365","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1095\/biolreprod.114.118513","article-title":"The LIF-mediated molecular signature regulating murine embryo implantation","volume":"91","author":"Rosario","year":"2014","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bbcan.2022.188737_bb0370","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1242\/dev.121.5.1283","article-title":"Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death","volume":"121","author":"Ware","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2022.188737_bb0375","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/en.2017-00103","article-title":"Tissue-specific ablation of the LIF receptor in the murine uterine epithelium results in implantation failure","volume":"158","author":"Cheng","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2022.188737_bb0380","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/aji.12474","article-title":"The multifaceted actions of leukaemia inhibitory factor in mediating uterine receptivity and embryo implantation","volume":"75","author":"Rosario","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0385","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/336684a0","article-title":"Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells","volume":"336","author":"Williams","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2022.188737_bb0390","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/genes2010280","article-title":"The role of the leukemia inhibitory factor (LIF) \u2013 Pathway in derivation and maintenance of murine pluripotent stem cells","volume":"2","author":"Graf","year":"2011","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbcan.2022.188737_bb0395","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1038\/s41598-021-82856-3","article-title":"Pluripotency and immunomodulatory signatures of canine induced pluripotent stem cell-derived mesenchymal stromal cells are similar to harvested mesenchymal stromal cells","volume":"11","author":"Shahsavari","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0400","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2022.188737_bb0405","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells \u2013 a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2022.188737_bb0415","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb3408","article-title":"Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow","volume":"18","author":"Johnson","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0420","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","article-title":"STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0425","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","article-title":"TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma","volume":"15","author":"Penuelas","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2022.188737_bb0430","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1101\/gad.1890510","article-title":"Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma","volume":"24","author":"Inda","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2022.188737_bb0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1101\/gad.1606508","article-title":"Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway","volume":"22","author":"de la Iglesia","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2022.188737_bb0440","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00125-005-0079-1","article-title":"Expression and function of leukaemia inhibitory factor and its receptor in normal and regenerating rat pancreas","volume":"49","author":"De Breuck","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbcan.2022.188737_bb0445","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3892\/or.2016.4865","article-title":"Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo","volume":"36","author":"Ma","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0450","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.2217\/fon-2019-0684","article-title":"Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma","volume":"16","author":"Wang","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0455","first-page":"90","article-title":"Expression and significance of leukemia inhibitory factor in human pancreatic cancer","volume":"94","author":"Peng","year":"2014","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.bbcan.2022.188737_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2022.188737_bb0465","doi-asserted-by":"crossref","first-page":"21949","DOI":"10.1038\/srep21949","article-title":"The structural basis of oncogenic mutations G12, G13 and Q61 in small GTPase K-Ras4B","volume":"6","author":"Lu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0470","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2022.188737_bb0475","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/s41467-019-11044-9","article-title":"Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2022.188737_bb0480","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1242\/jcs.075796","article-title":"Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF","volume":"124","author":"Tamm","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2022.188737_bb0485","first-page":"627","article-title":"Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: impact of CXCL-8 as an autocrine growth factor","volume":"31","author":"Kamohara","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0490","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-019-1130-6","article-title":"Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring","volume":"569","author":"Shi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2022.188737_bb0495","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0016-5085(03)01064-3","article-title":"Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer","volume":"125","author":"Scholz","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2022.188737_bb0500","first-page":"1","article-title":"Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma, Genes","volume":"10","author":"Hall","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2022.188737_bb0505","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1002\/jcp.27083","article-title":"Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest","volume":"234","author":"Xu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0510","doi-asserted-by":"crossref","first-page":"21137","DOI":"10.1074\/jbc.273.33.21137","article-title":"Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells","volume":"273","author":"Bellido","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2022.188737_bb0515","article-title":"Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis","volume":"1","author":"Liu","year":"2014","journal-title":"Mol. Cell Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0520","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/carcin\/bgv108","article-title":"LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase\/AKT pathway","volume":"36","author":"Luo","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2022.188737_bb0525","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.18632\/oncotarget.3136","article-title":"Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules","volume":"6","author":"Luo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2022.188737_bb0530","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.biocel.2005.02.025","article-title":"Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells","volume":"37","author":"Fitzgerald","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2022.188737_bb0535","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0897.2011.01037.x","article-title":"Reduction in miR-141 is induced by leukemia inhibitory factor and inhibits proliferation in choriocarcinoma cell line JEG-3","volume":"66","author":"Morales-Prieto","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0540","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1073\/pnas.92.12.5361","article-title":"Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation","volume":"92","author":"Schiemann","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2022.188737_bb0545","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.676","article-title":"Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1\/AKT\/GCN5 axis","volume":"12","author":"Ding","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2022.188737_bb0550","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2018.10.004","article-title":"Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer","volume":"440-441","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2022.188737_bb0555","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1038\/s41388-020-01468-9","article-title":"EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer","volume":"39","author":"Lin","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0560","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-012-2068-7","article-title":"Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor","volume":"135","author":"Iorns","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2022.188737_bb0565","doi-asserted-by":"crossref","first-page":"11465","DOI":"10.1038\/s41598-020-68158-0","article-title":"Immunization against leukemia inhibitory factor and its receptor suppresses tumor formation of breast cancer initiating cells in BALB\/c mouse","volume":"10","author":"Ghanei","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0570","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/bcr3349","article-title":"YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer","volume":"14","author":"Hergovich","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0575","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccell.2016.08.001","article-title":"Feedback activation of leukemia inhibitory factor receptor limits response to histone deacetylase inhibitors in breast cancer","volume":"30","author":"Zeng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2022.188737_bb0580","doi-asserted-by":"crossref","first-page":"17366","DOI":"10.18632\/oncotarget.3953","article-title":"MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway","volume":"6","author":"Nandy","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2022.188737_bb0585","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10059-011-0020-z","article-title":"Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer","volume":"31","author":"Shin","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2022.188737_bb0590","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/463081","article-title":"Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression and inhibits the proliferation of cervical carcinoma cells","volume":"2011","author":"Bay","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0595","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/ERC-11-0326","article-title":"Oncostatin M suppresses oestrogen receptor-alpha expression and is associated with poor outcome in human breast cancer","volume":"19","author":"West","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2022.188737_bb0600","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165107","article-title":"Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment","volume":"132","author":"Araujo","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2022.188737_bb0605","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jbmr.4430","article-title":"gp130 cytokines activate novel signaling pathways and alter bone dissemination in ER+ breast cancer cells","volume":"37","author":"Omokehinde","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0610","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/onc.2013.105","article-title":"Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer","volume":"33","author":"West","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0615","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3727\/096504017X14874349473815","article-title":"Leukemia inhibitory factor promotes aggressiveness of chordoma","volume":"25","author":"Gulluoglu","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123958","article-title":"The phosphoinositide 3-Kinase p110alpha isoform regulates leukemia inhibitory factor receptor expression via c-Myc and miR-125b to promote cell proliferation in medulloblastoma","volume":"10","author":"Salm","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2022.188737_bb0625","doi-asserted-by":"crossref","first-page":"8917","DOI":"10.1158\/0008-5472.CAN-10-0518","article-title":"Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0630","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI118167","article-title":"AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor\/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies","volume":"96","author":"Murakami-Mori","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2022.188737_bb0635","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s42003-021-02741-7","article-title":"LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer","volume":"4","author":"Li","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0640","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1535-7163.MCT-18-1258","article-title":"EC359: a first-in-class small-molecule inhibitor for targeting oncogenic lifr signaling in triple-negative breast cancer","volume":"18","author":"Viswanadhapalli","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2022.188737_bb0645","first-page":"977","article-title":"Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: involvement of regulation of LIF and its receptor expression","volume":"30","author":"Kamohara","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0650","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1158\/0008-5472.CAN-06-1021","article-title":"Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas","volume":"67","author":"Wysoczynski","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0655","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2007-02-072587","article-title":"Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells","volume":"110","author":"Duluc","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2022.188737_bb0660","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1038\/s41388-021-01931-1","article-title":"HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer","volume":"40","author":"Clements","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0665","doi-asserted-by":"crossref","first-page":"25484","DOI":"10.18632\/oncotarget.4688","article-title":"High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma","volume":"6","author":"Guo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2022.188737_bb0670","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12885-015-1177-1","article-title":"The leukemia inhibitory factor (LIF) and p21 mediate the TGFbeta tumor suppressive effects in human cutaneous melanoma","volume":"15","author":"Humbert","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2022.188737_bb0675","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/0008-5472.CAN-15-2790","article-title":"LIF drives neural remodeling in pancreatic cancer and offers a new candidate biomarker","volume":"78","author":"Bressy","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0680","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41598-017-00106-x","article-title":"ZEB1 regulates glioma stemness through LIF repression","volume":"7","author":"Edwards","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2022.188737_bb0685","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1038\/s41467-018-07660-6","article-title":"Cytoplasmic LIF reprograms invasive mode to enhance NPC dissemination through modulating YAP1-FAK\/PXN signaling","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2022.188737_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191865","article-title":"Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma","volume":"13","author":"Ohata","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2022.188737_bb0695","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1158\/1541-7786.MCR-19-0470","article-title":"Epigenetic profiling identifies LIF as a super-enhancer-controlled regulator of stem cell-like properties in osteosarcoma","volume":"18","author":"Lu","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0700","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41388-018-0523-6","article-title":"Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth","volume":"38","author":"McLean","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2022.188737_bb0705","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1189\/jlb.3MA1016-451RR","article-title":"TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs","volume":"102","author":"Won","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0710","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/dna.2017.4102","article-title":"Leukemia inhibitory factor receptor suppresses the metastasis of clear cell renal cell carcinoma through negative regulation of the yes-associated protein","volume":"37","author":"Lei","year":"2018","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082011","article-title":"Leukaemia inhibitory factor (LIF) inhibits cancer stem cells tumorigenic properties through hippo kinases activation in gastric cancer","volume":"12","author":"Seeneevassen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2022.188737_bb0720","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.18632\/oncotarget.4482","article-title":"Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K\/AKT-dependent Mcl-1 activation","volume":"6","author":"Morton","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2022.188737_bb0725","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.contraception.2012.09.032","article-title":"The LIF receptor antagonist PEGLA is effectively delivered to the uterine endometrium and blocks LIF activity in cynomolgus monkeys","volume":"87","author":"Aschenbach","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.bbcan.2022.188737_bb0730","doi-asserted-by":"crossref","first-page":"19357","DOI":"10.1073\/pnas.0710110104","article-title":"Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy","volume":"104","author":"White","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2022.188737_bb0735","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jir.2006.0138","article-title":"In vitro evaluation of leukemia inhibitory factor receptor antagonists as candidate therapeutics for inflammatory arthritis","volume":"27","author":"Jazayeri","year":"2007","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.bbcan.2022.188737_bb0740","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1074\/jbc.M310103200","article-title":"Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling","volume":"279","author":"Fairlie","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2022.188737_bb0745","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.nbd.2009.03.012","article-title":"Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina","volume":"34","author":"Chollangi","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbcan.2022.188737_bb0750","doi-asserted-by":"crossref","first-page":"26947","DOI":"10.1074\/jbc.272.43.26947","article-title":"An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M","volume":"272","author":"Vernallis","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2022.188737_bb0755","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s42003-021-01928-2","article-title":"An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy","volume":"4","author":"Hunter","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2022.188737_bb0760","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4014\/jmb.1501.01094","article-title":"Expression and efficient one-step chromatographic purification of a soluble antagonist for human leukemia inhibitory factor receptor in Escherichia coli","volume":"25","author":"Kim","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbcan.2022.188737_bib761","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.bbcan.2022.188737_bib762","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bbcan.2022.188737_bib763","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neo.2018.09.001","article-title":"MiPanda: A Resource for Analyzing and Visualizing Next-Generation Sequencing Transcriptomics Data","volume":"20","author":"Niknafs","year":"2018","journal-title":"Neoplasia"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X22000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X22000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:36:50Z","timestamp":1759639010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X22000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0304419X22000622"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2022.188737","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pleiotropic role, functions and targeted therapies of LIF\/LIFR axis in cancer: Old spectacles with new insights","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2022.188737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"188737"}}